Tag: AEZS

Blue Horseshoe Stocks: ISR, Bottom Plays & More

IsoRay, Inc. ISR

We first began tracking ISR back in early October as a potential bottom play, and just a few sessions subsequent to our first mention, we would witness a low of 1.22 (10/16).

It took just a couple of weeks for us to ride ISR to a 66% gain as it ran to a high of 2.03 at the end of October. It consolidated down from that level, and for the past month or so the stock has been trading channel between 1.50-1.70.

ISR is catching our attention once again this morning, as we picked up on a new update over the press wire regarding the company’s Cesium-131 low-dose radiation therapy for brain cancer sufferers (Learn More About Cesium-131).

The Barrow Neurological Institute conducted studies with 27 patients with several variations of brain cancer, and the company is reporting that there was no recurrence of the disease on the treated sites in 26 out of the 27 candidates, where other treatments had failed. >> Read PR

We’re going to be interested to see how the stock picks up trading following the holiday week, especially with such an encouraging piece of news out in the premarket. So far, the ISR has gone as high as 2.08 in preliminary trading this morning. We could be looking at a dip-and-scenario once the session commences; to remain interested we’ll want to see support hold at a minimum of 1.89 as that would mark a 50% retrace from the current premarket range.

Potential Bottom Plays

AEterna Zentaris, Inc. AEZS absolutely fell off a cliff back in early November, following FDA denial of a New Drug Application AEZS had submitted. The stock has spent the intervening time bottoming out, and it is now trading at all-time lows. This is exactly the sort of situation that sends us into “vulture-mode”, where we’re on the lookout for any signs of recovery after a stock has been hammered down.

Frontline, Ltd. FRO is a stock that is in the process of coming off of a recent bottom, and is showing signs of life here in today’s premarket, currently trading in the mid-1.30’s.

Extended Watchlist:
JNUG, GRPN, AG, ONNN

Blue Horseshoe Stocks: CDVI Recap, TINO Promotion & More

Cal Dive International, Inc. CDVI

On Tuesday, we introduced CDVI via our extended watchlist. We had been monitoring the stock after noticing it had taken a tremendous beating prior to that point. Some of our biggest gainers have come from recovery plays, and what we’ve seen from CDVI has been pleasing thus far.

Our timing in picking up on this play turned out to be on the nose, as it came from a new 52-week low of .08 on Tuesday, all the way back to .15 just prior to yesterday’s close. That represents an 87% rebound over the span of two sessions, so we’ll mark CDVI down as an excellent call on our part.

As far as how to approach it moving forward, we might want to take a listen to the Earnings Conference Call slated for 10AM EST today. The company released its Q3 financials after hours yesterday, and it will be interesting to hear the officials’ take on the results, which, at first glance, did include both positives and negatives, as well as future guidance . >>View PR

Either way, we’ve already had a major opportunity from this stock, so congrats to anyone who was able to turn a quick profit off of CDVI on its tremendous bottom-bounce.

Tamino Minerals, Inc. TINO

TINO is another one we want to mention briefly this morning, and enter it into our readers line of sight. The stock has been seeing a pickup in both volume and PPS over the past several sessions, with the effect intensifying toward the end of yesterday’s session.

It comes in advance of a large promotion occurring on the stock today. Let us be clear that we are not involved in today’s promotion on TINO, we simply wanted to pass that information along because it may be possible for us to take advantage of any surges it may produce. Should the stock begin to run, our mentality should be to snipe out quick gains before accumulation slopes off and the increase of selling pressure occurs. In these scenarios, it’s safer to shoot for rapid singles and doubles rather than holding on for a home run.

Extended Watchlist – Morning Gappers:

Gap-ups: CGG, PLNR, SFUN, PERI, RVLT, RDNT(Look for profit-taking to cause fade and subsequent bounce opportunities)

Gap-downs: AEZS, SZYM (Look for a potential bounce from over-selling)

Blue Horseshoe Stocks: NVAX, NQ & More

Novavax, Inc. NVAX 

NVAX is the latest Ebola-related stock to catch our eye, and while the initial fear that was driving a lot of these plays has calmed as people realize that the virus doesn’t exactly spread like wildfire, there is much being made of efforts to find a working vaccine and NVAX is attempting to answer that call.

The company announced today that it had presented at the 8th Vaccine and ISV Conference in Philadelphia on Sunday on what was called the first Ebola Vaccine Candidate based on the 2014 Guinea strain that caused the current outbreak in West Africa.

The company said it expects to begin Phase I testing by December, so we’re going to add NVAX to our watchlists for the time being. Additionally, the stock is gapping up to the tune of 10% here in the premarket, and the chart appears to have the possibility of a Golden Cross in the making.

NQ Mobile, Inc. NQ

This is a play we’ve tracked continuously since late this spring. After witnessing a nice move back in July from the low $4-range to the mid-$7’s, the stock had been under general consolidation until it found and bounced off of support about 6 weeks ago. It has made a nice steady recovery from that point on, and is gaining more traction this morning as it gaps up in the premarket on the heels of a PR.

The mobile security has just company submitted the necessary back-filings to once again become fully compliant, and no anomalies or adverse findings were uncovered, which adds another dimension to this play.

We also like the space NQ operates in- with mobile devices permeating every aspect of the current culture, the need for mobile security services such as those provided by NQ only stands to grow in the future.

Side Note:
PTIE, DRRX (Two that are gapping down significantly; we will want to watch for an eventual bounce)

Extended Watchlist:
ISR, AEZS, TSEM, CEMI,